David Evans
Analyst · J.P. Morgan. Please go ahead
Thanks Lynne. Total revenue for the fourth quarter was $47.8 million. Revenue within our core Cardlytics Direct business was $47.7 million, representing a 23% year-over-year growth rate over the fourth quarter 2017. Our U.S. direct business was up 26% year-over-year in Q4 and our U.K. direct business grew 11% at constant currency. For the full year, total revenue was $150.7 million with an increase of approximately 16% over 2017, while our core direct revenue of $149.3 million was up 22% over prior year. Average FI MAUs were approximately 42% from 58.7 million fourth quarter 2017 to 83.2 million in Q4 2018. Consistent with our recent commentary, we expect that FI MAU growth to continue to grow this year, driven by the national bank launches providing additional tailwind in 2020. Our fourth quarter 2018 ARPU was $0.57, down 14% from $0.66 in the fourth quarter of 2017, primarily reflecting the impact of rapid growth in average FI MAUs. Full year 2018 ARPU was $2.30 compared with $2.23 in 2017. As we've discussed, new MAUs have a maturation period before they reach their ARPU potential and expect this dynamic to play out for the foreseeable future going forward, and especially in 2019 where material FI MAU growth from national bank launches to cause a decrease of ARPU. As Scott mentioned earlier, we would expect to return to more normalized historical levels of ARPU in 2021, with revenues in excess of $300 million, coupled with consistent profitability. Longer term, we continue to believe this ramp in FI MAUs supports our revenue growth. Total adjusted contribution profit was $22.1 million in the fourth quarter of 2018, up from $17.4 million in the fourth quarter 2017. For the full year 2018, adjusted contribution profit was $69.5 million, up from $58.7 million in 2017. And Cardlytics Direct adjusted contribution profit was $69.4 million, up 26% from $55.2 million in 2017. Adjusted EBITDA was a positive of $300,000 in the fourth quarter of 2018 compared to a $500,000 gain in the fourth quarter of 2017. Our fourth quarter adjusted EBITDA was above our prior guidance primarily due to the revenue outperformance in the quarter and to a lesser extent coming in under budget on bank implementation expenses. Full year 2018, our adjusted EBITDA loss was negative $6.6 million, an improvement from a negative $7.2 million loss in 2017. We ended the quarter with $59.9 million of cash compared to $67.8 million in cash at the end of Q3 2018. Our cash balance includes approximately $20 million of restricted cash. We ended the quarter with $3.3 million on availability on our AR facility. I'd also like to talk about a few positive trends we've seen thus far in 2019. We are seeing positive trends in the number of marketers who are spending more with us. Additionally, already this year, we have seen the average contract length increased by over 50% for our larger marketers, demonstrating our continued push to move marketers to longer term contracts. We believe that these proof points position us well to continue growing and expanding existing advertiser budgets as well as sign new material and notable advertising clients in the coming months and years. Now, turning to our 2019 guidance, while we have gone to great length to analyze Chase's impact on revenue and are very pleased with the results so far, we are still in the very early stages of measuring our performance and analyzing what the steady state will look like. Adding to that, while we are still on target for a Wells launch in 2019, precise timing remains fluid and modeling the impacts to our 2019 results is, therefore, difficult. These two significant factors create a wide range of possible scenarios for our 2019 results. And as result, we're differing our full year 2019 guidance until our Q1 earnings release. We will have more experience with the expanded network and have an opportunity to analyze the new data and gain greater visibility. We will continue to provide quarterly guidance throughout 2019 and begin to provide guidance for adjusted contribution, which I'll explain shortly. For the first quarter, we currently expect revenue to be between $34.5 million and $36.5 million. We expect adjusted EBITDA loss for the first quarter to be between negative $6.5 million and negative $5.5 million. We expect adjusted contribution for the first quarter to be between $15.5 million and $16.5 million. Our decision to guide adjusted contribution stems from the complexities and nuances surrounding our network of FI partners. As Lynne mentioned, we will always strive to ensure the successful launch with national bank partner and in doing so, we'll encourage and adopt various activities to ensure customers and advertisers engage with the platform. As we continue to monitor the effects, we've seen new developments take place, one in particular that impacts our GAAP revenue. Our banking partners are embracing our program by reinvesting more of their FI shares into the program in the form of larger consumer incentives and attractive offers. We're referring to these as enhanced consumer incentives. Therefore, there can be a shift of dollars into consumer incentive from FI share. And as you'll recall, our GAAP revenue is billing less consumer incentive. So, while this does suppress our revenue, it is important to understand that this has a netting effect to adjusted contribution and adjusted EBITDA. Longer term, we believe this has a very positive effect on improving engagement and the stickiness of Cardlytics Direct with consumers. Therefore, providing adjusted contribution guidance provides a better view as it relates to the performance of our business. Separately, to help with your modeling and as we've previously discussed, we currently expect FI share commitment shortfall in 2019 to be between $5 million and $6 million. We expect this accrual to begin in the second quarter of 2019, in which phase, we would anticipate the shortfall in the 12 months thereafter. With that, I'll hand it back over to Scott for his closing remarks before we open the call to your questions. Scott?